Can nanomedicines really offer pharma a compelling alternative approach to precision medicines?
Delivering accurate diagnosis for clinicians, safer medicines for patients and lower costs through reduced waste and costly hospitalisations for payers: everyone's a winner! While nanomedicines are not new, it is the next generation of nanotechnology that has the potential to be a game changer for how pharma develops and monetises its therapies. This disruptive technology offers pharma a visionary business model–the question is how, and where, are the nanomedicine wins in the short and long term, and what must Pharma do now to really benefit in the future?
In The Impact of Nanomedicine in the Pharma Industry we interviewed leading nanomedicine experts to help you identify where nanomedicines are now and the future high-impact technologies that pharma must focus on..
Experts scan the nanomedicines horizon
What nanomedicine experts say…
"There's an enormous gulf between efficacy as measured in clinical studies and real world effectiveness. All around the world, the average adherence to medicines is under 50 percent, and it's overly simplistic to blame the patients. Nanomedicine has the opportunity to address what is potentially the biggest public health problem there is out there."
US Nanomedicine Expert
"In terms of the application, I am seeing a trend to run towards more immunology or even neonatology applications, where you're activating the immune system. I'm also seeing a trend towards combination therapies…everyone agrees that nanotechnology for many, many drugs can at least open the therapeutic window on the safety side of things, which is often a larger problem to overcome when dosing drugs in combination."
US Nanomedicine Expert
"One of the hottest issues now is how to use exosomes as drug delivery systems, because of their lack of immunogenicity. How can we use exosomes to modulate the biological background of healthy tissues to change immunological aspects of the human body?"
"EU Nanomedicine Expert
What to expect
Expert contributors
The report harnesses critical insights from front line experts who completely understand the current and future potential of nanomedicine. In order to allow for candid responses, we have agreed to keep some of their names anonymous.
Why choose FirstWord FutureViews reports?
FirstWord's FutureViews reports analyse in detail significant emerging technology and market trends that pharma executives need to understand if they are to manage the opportunities and challenges that lay ahead. These concise and highly focussed reports:
All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved